General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.
Monday, 25 February 2019
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations
General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment